These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

154 related articles for article (PubMed ID: 7712485)

  • 1. Drug resistance and gene amplification potential regulated by transforming growth factor beta 1 gene expression.
    Huang A; Jin H; Wright JA
    Cancer Res; 1995 Apr; 55(8):1758-62. PubMed ID: 7712485
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Protein alterations associated with gene amplification in cultured human and rodent cells.
    Conner EA; Wirth PJ
    Electrophoresis; 1996 Jul; 17(7):1257-64. PubMed ID: 8855414
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Overexpression of the 18 kDa and 22/24 kDa FGF-2 isoforms results in differential drug resistance and amplification potential.
    Dini G; Funghini S; Witort E; Magnelli L; Fanti E; Rifkin DB; Del Rosso M
    J Cell Physiol; 2002 Oct; 193(1):64-72. PubMed ID: 12209881
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Ribonucleotide reductase R2 gene expression and changes in drug sensitivity and genome stability.
    Huang A; Fan H; Taylor WR; Wright JA
    Cancer Res; 1997 Nov; 57(21):4876-81. PubMed ID: 9354452
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Fibroblast growth factor mediated alterations in drug resistance, and evidence of gene amplification.
    Huang A; Wright JA
    Oncogene; 1994 Feb; 9(2):491-9. PubMed ID: 7904743
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Aberrant expression of basic fibroblast growth factor in NIH-3T3 cells alters drug resistance and gene amplification potential.
    Huang A; Jin H; Wright JA
    Exp Cell Res; 1994 Aug; 213(2):335-9. PubMed ID: 8050490
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Inefficient growth arrest in response to dNTP starvation stimulates gene amplification through bridge-breakage-fusion cycles.
    Poupon MF; Smith KA; Chernova OB; Gilbert C; Stark GR
    Mol Biol Cell; 1996 Mar; 7(3):345-54. PubMed ID: 8868464
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Multiple mechanisms of N-phosphonacetyl-L-aspartate resistance in human cell lines: carbamyl-P synthetase/aspartate transcarbamylase/dihydro-orotase gene amplification is frequent only when chromosome 2 is rearranged.
    Smith KA; Chernova OB; Groves RP; Stark MB; Martínez JL; Davidson JN; Trent JM; Patterson TE; Agarwal A; Duncan P; Agarwal ML; Stark GR
    Proc Natl Acad Sci U S A; 1997 Mar; 94(5):1816-21. PubMed ID: 9050862
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Properties of single-step mutants of Syrian hamster cell lines resistant to N-(phosphonacetyl)-L-aspartate.
    Zieg J; Clayton CE; Ardeshir F; Giulotto E; Swyryd EA; Stark GR
    Mol Cell Biol; 1983 Nov; 3(11):2089-98. PubMed ID: 6656764
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Late onset of CAD gene amplification in unamplified PALA resistant Chinese hamster mutants.
    Mucciolo E; Bertoni L; Mondello C; Giulotto E
    Cancer Lett; 2000 Mar; 150(2):119-27. PubMed ID: 10704733
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Mechanism of resistance of variants of the Lewis lung carcinoma to N-(phosphonacetyl)-L-aspartic acid.
    Kensler TW; Mutter G; Hankerson JG; Reck LJ; Harley C; Han N; Ardalan B; Cysyk RL; Johnson RK; Jayaram HN; Cooney DA
    Cancer Res; 1981 Mar; 41(3):894-904. PubMed ID: 7459875
    [TBL] [Abstract][Full Text] [Related]  

  • 12. MYC abrogates p53-mediated cell cycle arrest in N-(phosphonacetyl)-L-aspartate-treated cells, permitting CAD gene amplification.
    Chernova OB; Chernov MV; Ishizaka Y; Agarwal ML; Stark GR
    Mol Cell Biol; 1998 Jan; 18(1):536-45. PubMed ID: 9418900
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Transforming growth factor beta 1 suppresses genomic instability independent of a G1 arrest, p53, and Rb.
    Glick AB; Weinberg WC; Wu IH; Quan W; Yuspa SH
    Cancer Res; 1996 Aug; 56(16):3645-50. PubMed ID: 8706000
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Increased gene amplification in immortal rodent cells deficient for the DNA-dependent protein kinase catalytic subunit.
    Mondello C; Rebuzzini P; Dolzan M; Edmonson S; Taccioli GE; Giulotto E
    Cancer Res; 2001 Jun; 61(11):4520-5. PubMed ID: 11389084
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The propensity for gene amplification: a comparison of protocols, cell lines, and selection agents.
    Sharma RC; Schimke RT
    Mutat Res; 1994 Jan; 304(2):243-60. PubMed ID: 7506368
    [TBL] [Abstract][Full Text] [Related]  

  • 16. p53-dependent growth arrest of REF52 cells containing newly amplified DNA.
    Ishizaka Y; Chernov MV; Burns CM; Stark GR
    Proc Natl Acad Sci U S A; 1995 Apr; 92(8):3224-8. PubMed ID: 7724543
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Multiple mechanisms of N-(phosphonoacetyl)-L-aspartate drug resistance in SV40-infected precrisis human fibroblasts.
    Schaefer DI; Livanos EM; White AE; Tlsty TD
    Cancer Res; 1993 Oct; 53(20):4946-51. PubMed ID: 8402685
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Inhibition of gene amplification in telomerase deficient immortalized mouse embryonic fibroblasts.
    Rebuzzini P; Martinelli P; Blasco M; Giulotto E; Mondello C
    Carcinogenesis; 2007 Mar; 28(3):553-9. PubMed ID: 16973670
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Mechanism-based model for tumor drug resistance.
    Kuczek T; Chan TC
    Cancer Chemother Pharmacol; 1992; 30(5):355-9. PubMed ID: 1505073
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Gene amplification and gene deletion are induced at different rates in V79/AP4 Chinese hamster cells.
    Vatteroni L; Piras A; Moretti A; Rainaldi G
    Mutagenesis; 1993 Sep; 8(5):411-5. PubMed ID: 7901735
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.